Ovine model and vaginal microbiome support for HIV nonvaccine biomedical prevention product development.
Ended Awarded Last action
- Contract number
- HHSN27200005
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $255,138
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2015029 Solicitation number
- Comprehensive Resources for HIV Microbicides and Biomedical Prevention Award Notice · Posted Jun 24, 2015
- Contract value 41% obligated
-
- $255,137.51 Current, with exercised options
- $616,640.51 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $2,998 | |
| Funding Only Action | -$3,604 | |
| Funding Only Action | $6,658 | |
| Exercise an Option | $85,069 | |
| Exercise an Option | $83,017 | |
| Other Administrative Action | $0 | |
| Original award | $80,999 |
About this award
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit manufacturer of goods. The $616,640.51 cost-plus-fixed-fee contract, which is not set aside, supports the "OVINE MODEL AND VAGINAL MICROBIOME SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT" under NIAID's "COMPREHENSIVE RESOURCES FOR HIV MICROBICIDES AND BIOMEDICAL PREVENTION" major program. This delivery order contract is part of NIAID's HIV Microbicides and Biomedical Prevention 2016-2021 Indefinite Delivery Vehicle (IDV). ABL, a leading contract research and manufacturing organization, will provide a variety of preclinical development services to support the advancement of HIV prevention products, leveraging its expertise in areas such as biologics manufacturing, testing, and quality assurance.
Quick answers
Who was awarded contract HHSN27200005?
HHSN27200005 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 31, 2017.
How much is contract HHSN27200005 worth?
The government has obligated $255,138 on HHSN27200005. Its potential value, with all options, is $616,641.
Is contract HHSN27200005 an order under another contract?
Yes. HHSN27200005 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract HHSN27200005 competed?
The extent of competition for HHSN27200005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award